23.02.2018 | short review
Targeting angiogenesis in lung cancer
Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2018Einloggen, um Zugang zu erhalten
Angiogenesis inhibition is a promising way to inhibit and eradicate cancer. Many attempts have been made to use this tool for the treatment of lung cancer. Some success has been reported, and antiangiogenic drugs are actively being investigated in combination with other types of anticancer treatments.